DOP051 Serological biomarkers of tissue turnover can early identify responders to infliximab in Crohn's disease W.T. van Haaften, J.H. Mortensen,M.L. Olesen,M.A. Karsdal,P. Olinga,A.-C. Bay-Jensen,G. DijkstraJournal of Crohn's and Colitis(2017)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要